US · benefits management · healthtech · pharmacy
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series F · Sept 2025 · $252M
General Catalyst lead, Wellington Management lead
Reported by AlleyWatch · SEC filing: $231M sold under the offering, first sale Aug 2025
Missing a round, or an investor who was in one? Tell us.